Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000593911 | SCV000707892 | uncertain significance | not provided | 2017-04-17 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001124746 | SCV001283733 | likely benign | Renal cysts and diabetes syndrome | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Clinical Genomics, |
RCV002465734 | SCV002754394 | uncertain significance | Maturity onset diabetes mellitus in young | criteria provided, single submitter | research | HNF1B gene mutations are associated with early onset diabetes and pancreatic atrophy. It is also associated with multiple renal manifestations including renal cysts, Tubulointerstitial disease, glomerulocystic disease, renal hypoplasia, hypomagnesemia. However no sufficient evidence is found to ascertain the role of this particular variant rs751225159, yet. | |
Gene |
RCV000593911 | SCV004039975 | uncertain significance | not provided | 2023-03-31 | criteria provided, single submitter | clinical testing | In silico analysis supports that this variant does not alter splicing; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV000593911 | SCV004635963 | likely benign | not provided | 2023-08-28 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000593911 | SCV001977950 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000593911 | SCV001980478 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003945429 | SCV004762838 | likely benign | HNF1B-related disorder | 2021-03-29 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |